President Trump relied heavily on testing as protection against COVID exposure, eschewing masks and social distancing.
El diagnóstico de COVID-19 del presidente Donald Trump está generando nuevas preguntas sobre la estrategia de la Casa Blanca para realizar pruebas y contener la propagación del virus.
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Experts say the administration’s approach with antigen tests could add cost and risk for the most vulnerable patients.
State officials said they urgently needed millions more masks and gowns, internal emails show. At least 80 Georgia health workers have died from COVID-19, including after the state reopened its economy.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.
Although laws prohibit price gouging on precious resources in times of emergency, states have been forced to compete for a share of the nation’s stockpile of ventilators — used to treat the sickest COVID patients — or pay top dollar on sideline deals. With quality and quantity control lacking, what happens when the pandemic’s second wave hits?